Evaluation of the GORE Conformable TAG® for Treatment of Traumatic Transection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Farber, M.D.
University of North Carolina, Chapel Hill
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Stanford, California, United States
- Facility name not stated
Jacksonville, Florida, United States
- Facility name not stated
Tampa, Florida, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Ann Arbor, Michigan, United States
- Facility name not stated
Minneapolis, Minnesota, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Omaha, Nebraska, United States
- Facility name not stated
Lebanon, New Hampshire, United States
- Facility name not stated
Lake Success, New York, United States
- Facility name not stated
Chapel Hill, North Carolina, United States
- Facility name not stated
Charlotte, North Carolina, United States
- Facility name not stated
Greenville, North Carolina, United States
- Facility name not stated
Cincinnati, Ohio, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
- Facility name not stated
Pittsburgh, Pennsylvania, United States
- Facility name not stated
Charleston, South Carolina, United States
- Facility name not stated
Greenville, South Carolina, United States
- Facility name not stated
Knoxville, Tennessee, United States
- Facility name not stated
Nashville, Tennessee, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
Temple, Texas, United States
- Facility name not stated
Seattle, Washington, United States
- Facility name not stated
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2009
- Primary completion
- 28 Feb 2011
- Completion
- 28 Feb 2017
- Last update posted
- 25 Aug 2017
- Registered enrollment
- 51
- Registry id
- NCT00917852
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.